Postmarketing Requirements Will Be "Studies" Unless "Trials" Are Needed, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Draft guidance lays out the FDAAA-mandated distinction, but also suggests that the agency continues to be much more comfortable with clinical trials than observational studies.